| Identification | More | [Name]
Diethyl methylphosphonate | [CAS]
683-08-9 | [Synonyms]
AURORA KA-1413
DIETHYL METHANEPHOSPHONATE
DIETHYL METHYLPHOSPHONATE
METHYLPHOSPHONIC ACID DIETHYL ESTER
DEMP
Diethoxymethylphosphine oxide
diethylmethanephosphate
methyl-phosphonicacidiethylester
o,o-Diethyl methylphosphonate
Phosphonic acid, methyl-, diethyl ester
Phosphonicacid,methyl-,diethylester
Diethyl methanephosphonate, 98+%
Diethylmethylphosphonate,97%
DIETHYL METHANEPHOSPONATE
Diethylmethylphosphonate, 98 %
Diethyl methylphosphonate: (DEMP)
1-(Ethoxy-methylphosphoryl)oxyethane
Methylphosphonic acid diethyl | [EINECS(EC#)]
211-667-4 | [Molecular Formula]
C5H13O3P | [MDL Number]
MFCD00009813 | [Molecular Weight]
152.13 | [MOL File]
683-08-9.mol |
| Chemical Properties | Back Directory | [Appearance]
clear colorless liquid | [Boiling point ]
194 °C(lit.)
| [density ]
1.041 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.414(lit.)
| [Fp ]
168 °F
| [storage temp. ]
Hygroscopic, Refrigerator, under inert atmosphere | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Liquid | [color ]
Clear colorless to pale yellow | [Water Solubility ]
Miscible with water. | [BRN ]
1753416 | [Stability:]
Hygroscopic | [CAS DataBase Reference]
683-08-9(CAS DataBase Reference) | [NIST Chemistry Reference]
Diethyl methanephosphonate(683-08-9) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
3
| [RTECS ]
SZ9085000
| [HS Code ]
29310095 |
| Hazard Information | Back Directory | [Chemical Properties]
clear colorless liquid | [Uses]
Diethyl methylphosphonate is used as a precursor for the synthesis of gem-difluroalkenyphosphonate via reaction with alpha-trifluromethylstyrene. It is also used in the synthesis of phosphonylated peptides, fluoroalkyl alpha- and beta-aminophosphonates, pyridone alkaloids with neuritogenic activity and lipophilic meropenem-derived prodrugs. |
|
|